Tobacco dependence : a comprehensive guide to prevention and treatment / Michelle N. Eakin, Hasmeena Kathuria, editors.
This book is a guide to pharmacotherapy treatment of tobacco dependence. The 2020 American Thoracic Society clinical practice guidelines on treating tobacco dependence serves as the cornerstone for this work with its robust discussion of recommended treatment options and how to tailor treatment to s...
Saved in:
| Online Access: |
Full Text (via Springer) |
|---|---|
| Other Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Cham :
Humana Press,
2023.
|
| Series: | Respiratory medicine (New York, N.Y.)
|
| Subjects: |
MARC
| LEADER | 00000cam a22000007a 4500 | ||
|---|---|---|---|
| 001 | b12899819 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 230304s2023 sz o 001 0 eng d | ||
| 005 | 20240423173516.8 | ||
| 019 | |a 1371484371 | ||
| 020 | |a 9783031249143 |q (electronic bk.) | ||
| 020 | |a 3031249143 |q (electronic bk.) | ||
| 020 | |z 9783031249136 | ||
| 024 | 7 | |a 10.1007/978-3-031-24914-3 | |
| 035 | |a (OCoLC)spr1371752871 | ||
| 035 | |a (OCoLC)1371752871 |z (OCoLC)1371484371 | ||
| 037 | |a spr978-3-031-24914-3 | ||
| 040 | |a EBLCP |b eng |c EBLCP |d GW5XE |d YDX | ||
| 049 | |a GWRE | ||
| 050 | 4 | |a RC567 | |
| 245 | 0 | 0 | |a Tobacco dependence : |b a comprehensive guide to prevention and treatment / |c Michelle N. Eakin, Hasmeena Kathuria, editors. |
| 260 | |a Cham : |b Humana Press, |c 2023. | ||
| 300 | |a 1 online resource (302 p.) | ||
| 336 | |a text |b txt |2 rdacontent. | ||
| 337 | |a computer |b c |2 rdamedia. | ||
| 338 | |a online resource |b cr |2 rdacarrier. | ||
| 490 | 1 | |a Respiratory Medicine. | |
| 505 | 0 | |a Intro -- Preface -- Contents -- Contributors -- Chapter 1: Current Patterns of Tobacco Use and Health Disparities -- Introduction -- Health Equity in the Context of Tobacco and Understanding Tobacco-Related Disparities -- Why Should We Recognize Tobacco-Related Disparities? -- Poorer Outcomes for Those Who Face Disparities -- Higher Cost for Those Who Face Disparities -- Higher Tobacco Use and Secondhand Smoke Exposure Among Those Impacted by Tobacco-Related Disparities -- Patterns of Tobacco Use in Various Populations -- Age -- Education -- Gender -- Race/Ethnicity -- Income/Poverty. | |
| 505 | 8 | |a Other Tobacco Products (OTP) -- Secondhand Smoke Exposure -- Sexual Orientation and Gender Identity -- Substance Use and Mental Health Disorders -- Occupation and Veteran Status -- Disability -- Geography -- Incarcerated People -- Why Do Tobacco-Related Disparities Exist? -- Social Determinants of Health -- Targeted Marketing by the Tobacco Industry -- Lack of Comprehensive Policies -- Changing US Population -- What Can We Do to Eliminate Disparities and Achieve Health Equity? -- Increasing Diversity of the Healthcare Team -- Address Inequities in Research. | |
| 505 | 8 | |a Solving Inequalities in Access, Quality of Care, and Socioeconomic Status -- Implementing Appropriate Tobacco Control Policies -- References -- Chapter 2: Adverse Effects of Tobacco Products (Cigarettes, E-Cigarettes, Hookah, Smokeless Tobacco) Use on Health -- Introduction: Impact on Health of All Tobacco Products -- Mechanism of Injury of Tobacco Products -- Pathophysiology -- Oxidative Stress -- Genetics and Epigenetics -- Endothelial Dysfunction -- Inflammation and Infection -- Hemodynamic Effects -- Thrombogenic Effects -- Hormonal Alterations -- Lipid Abnormalities. | |
| 505 | 8 | |a Specific Pathophysiology Related to Modes of Delivery and Additive Toxins -- Cigarettes -- Hookah -- Vaping and Electronic Nicotine Delivery Systems (ENDS) -- Smokeless Tobacco -- Organ-Specific Morbidity and Mortality Attributed to Tobacco Product Use -- Pulmonary Manifestations -- Acute Respiratory Infection -- Chronic Obstructive Pulmonary Disease (COPD) -- Asthma -- Respiratory Bronchiolitis Associated Interstitial Lung Disease (RB-ILD) -- Desquamative Interstitial Pneumonia (DIP) -- Pulmonary Langerhans Cell Histiocytosis (PLCH) -- Cardiovascular Manifestations -- Subclinical Atherosclerosis. | |
| 505 | 8 | |a Peripheral Arterial Disease -- Coronary Heart Disease -- Cerebrovascular Disease -- Aortic Aneurysm -- Atrial Fibrillation -- Oncological Manifestations -- Lung -- Head and Neck -- Gastrointestinal (Esophageal, Gastric, Colorectal, Hepatobiliary, Pancreas) -- Genitourinary -- Blood -- Reproductive Manifestations -- Female Reproductive Health -- Male Reproductive Health -- Pregnancy Complications -- Perinatal and Infant Morbidity and Mortality -- Endocrine Manifestations -- Neuropsychiatric Manifestations -- Miscellaneous Manifestations -- Health Benefits of Cessation -- Summary -- References. | |
| 500 | |a Chapter 3: Neurobiology and Mechanisms of Nicotine Addiction. | ||
| 500 | |a Includes index. | ||
| 520 | |a This book is a guide to pharmacotherapy treatment of tobacco dependence. The 2020 American Thoracic Society clinical practice guidelines on treating tobacco dependence serves as the cornerstone for this work with its robust discussion of recommended treatment options and how to tailor treatment to specific patient populations. Tobacco dependence remains a major health concern for many adults and given the dramatic increase of youth electronic cigarette use, clinicians need a singular resource to treat these different populations. This book addresses that by following the three main points of how to best address the adverse impact of tobacco use on public health: 1) prevent initiation of tobacco use; 2) understand mechanisms of addiction; 3) effectively treat tobacco dependence. The book begins by describing the current patterns of product use, the adverse impact of tobacco on global health, and tobacco-related health disparities. Authors discuss both combustible and electronic tobacco products, as well as current research on the adverse impact of vaping and associated flavorings including menthol, role of the e-cigarette in cessation, and treatment of adolescent nicotine dependence. Chapters conclude with a discussion of specific tobacco control policies to improve overall public health. This is an ideal guide for pulmonologists, pediatricians, primary care physicians and other specialty providers who see patients with nicotine dependence. This book is also of interest to public health professions to help inform public health campaigns and treatment offerings to reduce overall tobacco product use through prevention and treatment. | ||
| 588 | 0 | |a Print version record. | |
| 650 | 0 | |a Nicotine addiction |x Treatment. | |
| 650 | 0 | |a Nicotine addiction |x Prevention. | |
| 650 | 0 | |a Tobacco use |x Prevention. | |
| 700 | 1 | |a Eakin, Michelle N. | |
| 700 | 1 | |a Kathuria, Hasmeena. | |
| 776 | 0 | 8 | |i Print version: |a Eakin, Michelle N. |t Tobacco Dependence |d Cham : Springer International Publishing AG,c2023 |z 9783031249136. |
| 776 | 0 | 8 | |i Print version: |t Tobacco dependence |z 9783031249136 |w (OCoLC)1371818149. |
| 830 | 0 | |a Respiratory medicine (New York, N.Y.) | |
| 856 | 4 | 0 | |u https://colorado.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-3-031-24914-3 |z Full Text (via Springer) |
| 907 | |a .b128998192 |b 03-15-23 |c 03-15-23 | ||
| 998 | |a web |b - - |c f |d b |e - |f eng |g sz |h 0 |i 1 | ||
| 915 | |a 7 | ||
| 956 | |a Springer e-books | ||
| 956 | |b Springer Nature - Springer Medicine eBooks 2023 English International | ||
| 999 | f | f | |i bf2af951-54dc-5a41-a03f-ae9302b3d9d9 |s 9350ef69-b317-5b11-8551-eb978788e156 |
| 952 | f | f | |p Can circulate |a University of Colorado Boulder |b Online |c Online |d Online |e RC567 |h Library of Congress classification |i Ebooks, Prospector |n 1 |